Our Strategy

We develop high quality novel and affordable vaccines and biologics from concept to Phase I/II clinical stage and proof of concept. Our focus is on robust science and validated manufacturing processes and platforms to enable late-stage development and large-scale manufacturing. We partner with commercial manufacturers in developing and developed countries.

Our scope is to develop vaccines and biologics for the prevention of viral and bacterial infections with large unmet medical needs in poor settings, using established, novel and safe vaccine and biologics platforms.